(Q38433563)

3 September 2017

title

Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study (English)

1 reference

3 September 2017

0 references

1 reference

Patrick Imfeld

1

1 reference

3 September 2017

Michael Bodmer

series ordinal

2

1 reference

3 September 2017

Susan S Jick

series ordinal

3

1 reference

3 September 2017

Christoph R Meier

series ordinal

4

1 reference

3 September 2017

language of work or name

English

0 references

publication date

28 March 2012

1 reference

Journal of the American Geriatrics Society

3 September 2017

published in

1 reference

3 September 2017

volume

60

1 reference

3 September 2017

issue

5

1 reference

3 September 2017

page(s)

916-921

1 reference

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Validation of information recorded on general practitioner based computerised data resource in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Validity of the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Association between dementia and infectious disease: evidence from a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Education and dementia: what lies behind the association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

21 January 2018

A database worth saving

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.03916.X

10.1111/J.1532-5415.2012.03916.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference